MediWound (NASDAQ:MDWD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research report issued to clients and investors on Thursday,Benzinga reports.

Avantax Advisory Services Inc. boosted its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 1.7% during the 4th quarter ...

Reported positive results from the Expanded Access Protocol (NEXT), reinforcing NexoBrid's clinical and real-world benefits across 29 burn centers in the U.S. The study included 239 patients (215 ...

Raw wounds erupt into a scaly crust of dead tissue called eschar which, if untreated, can lead to amputation. The use of tranq in Philadelphia has risen in recent years. The city's public health ...

Typical lesions progress from red or gray macules or papules, to red or gray macules or papules with a central eschar or ulceration. This evolution is a consequence of the thrombosis of dermal ...

Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for ...

After hours: March 20 at 5:42:01 PM EDT Loading Chart for VCEL ...

After hours: March 18 at 4:05:07 PM EDT Loading Chart for MDWD ...